Laure Ory-Lavollée
Nessuna posizione attualmente
Profilo
Laure Ory-Lavollée, who worked at Diatos SA and Cellectis SA, was a director at both firms.
She also worked as an analyst at Puilaetco in 2002.
Precedenti posizioni note di Laure Ory-Lavollée
| Società | Posizione | Fine |
|---|---|---|
Diatos SA
 Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France. | Direttore/Membro del Consiglio | 15/09/2009 |
| Puilaetco | Analyst-Equity | 15/05/2002 |
| CELLECTIS S.A. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CELLECTIS S.A. | Health Technology |
| Aziende private | 2 |
|---|---|
Diatos SA
Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France. | Health Technology |
| Puilaetco | Finance |
- Borsa valori
- Insiders
- Laure Ory-Lavollée
